Bioventix 产品代理
Bioventix 产品代理
专注于临床诊断和药物滥用检测领域，该公司的战略是确定新的或现有的商业检测方法，其中存在或可能需要改进抗体。我们的目标是为客户提供高质量的SMA，以解决其他抗体的缺点。在Bioventix产生的高亲和力抗体比传统啮齿类单克隆抗体具有优势，这些抗体的靶点浓度较低，或者靶点是短肽序列，或者靶点是小分子或药物。在许多分析格式中，使用高亲和力SMA可提高分析灵敏度和精确度。
Bioventix已成功开发出SMA，用于传统单克隆或多克隆抗体无法产生合适试剂的目标，并为几乎所有全球跨国免疫诊断公司提供抗体。
Thyroid
Vitamin D
Cardiac
Drugs of Abuse
Fertility
Infectious Disease
Oncology
Miscellaneous
Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.
Focusing on the areas of clinical diagnostics and drugs of abuse testing the Company’s strategy is to identify new or existing commercial assays for which there is or may be a need for improved antibodies. We aim to provide clients with high quality SMAs that address the shortcomings of other antibodies. The high-affinity antibodies created at Bioventix have advantages over conventional rodent monoclonal antibodies where the target is present at low concentration, or where the target is a short peptide sequence or where the target is a small molecule or drug. In many assay formats, the use of high-affinity SMAs confers improved assay sensitivity and precision.
Bioventix has successfully developed SMAs to targets where conventional monoclonal or polyclonal antibodies have failed to produce a suitable reagent and supplies antibodies to almost all of the global multinational immunodiagnostics companies.
